MedPath

pH monitoring in the esophago-gastric junction and stomach beore and after esophageal variceal treatment

Phase 2
Conditions
1) Patients between 20 and 80 years old. 2) Patients have esophageal varices which could be treated by EVL therapy. 3) Patients with liver cirrhosis are Child-Pugh Classification (A or B).
Registration Number
JPRN-UMIN000008337
Lead Sponsor
Kitasato University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Ongoing pharmacological acid supressive therapy; Drinking alcohol within 3 months before the start of the study; Child-Pugh score Hepatocellular carcinoma (HCC); Portal thrombosis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparing of 24 hours under pH 4 holding time (%) between beore and after EVL therapy in the esophago-gastric junction
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath